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tivecommons.org/licenses/by-nc-Summary Paraganglioma is a rare extra-adrenal pheochromocytoma which originates from
chromaffin cells within the ganglia of the sympathetic trunk and of the celiac, renal, suprare-
nal, and hypogastric plexuses. Pancreatic paragangliomas are rarer still. And even then, para-
gangliomas are mostly reported to be nonfunctional. We report a case of a 64-year-old woman
with underlying disease of hypertension who presented with biliary colic. Contrast-enhanced
computer tomography showed an enhancing mass in the uncinate process of the pancreas.
Pylorus-sparing Whipple procedure was performed for complete tumor excision. Hypertensive
crisis developed after Whipple, which improved after continuous intravenous nicardipine infu-
sion. Pathology revealed a paraganglioma. A 24-h catecholamine urine test showed increased
norepinephrine and vanillylmandelic acid level. Functional paraganglioma was diagnosed.
Copyright ª 2016, The Gastroenterological Society of Taiwan, The Digestive Endoscopy Society
of Taiwan and Taiwan Association for the Study of the Liver. Published by Elsevier Taiwan LLC.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Introduction
Paragangliomas originate from chromaffin cells within the
ganglia of the sympathetic trunk and of the celiac, renal,
suprarenal, and hypogastric plexuses. They occur from theent of Internal Medicine,
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nd/4.0/).skull base to the pelvis, and the most common location
being the retroperitoneum. Pancreatic paragangliomas are
rare and most are nonfunctional. Herein, we report a case
with a functional pancreatic paraganglioma and provide a
review of the features associated with the tumor.Case Report
A 64-year-old woman with past medical history significant
for hypertension had visited the emergency department, The Digestive Endoscopy Society of Taiwan and Taiwan Association
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Figure 2 Axial contrast enhanced computed tomography
abdomen demonstrated a 1.6-cm enhancing mass (arrow) in
the uncus of the pancreas.
Pancreatic paraganglioma 133many times over the course of several years due to inter-
mittent hypertensive emergencies. On this presentation,
she was admitted with features of symptomatic choleli-
thiasis. Abdominal ultrasound confirmed the presence
gallstones and incidentally showed a 1.5-cm hypoechoic
mass in the uncinate process of the pancreas (Figure 1). A
physical examination was unremarkable except for mild
right upper quadrant tenderness and elevated blood pres-
sure (211/112 mmHg). Serum carcinoembryonic antigen and
carbohydrate antigen 19-9 levels were both within normal
limits. Contrast-enhanced computer tomography showed a
1.6-cm enhancing mass in the uncinate process of the
pancreas (Figure 2). On magnetic resonance imaging, the
lesion was identified as a 1.6-cm low-intensity mass on
T1-weighted imaging and a slightly high-intensity mass on
T2-weighted imaging. Magnetic resonance imaging with
contrast enhancement revealed that the lesion was
enhanced (Figure 3). On the basis of these findings, pre-
operative diagnosis was a pancreatic hypervascular tumor,
suspected to be a neuroendocrine tumor. A pylorus-sparing
Whipple procedure was recommended to achieve complete
excision of the tumor and to treat the symptomatic chole-
lithiasis. Grossly, an oval and well encapsulated tumor
measuring 1.5 cm in greatest dimension was noted within
the lower part of uncinate process. Microscopically, this
well-encapsulated tumor was composed of proliferation of
polygonal cells arranged in trabecular, nest, and alveolar
patterns separated by a stroma rich in vascular network.
The tumor cells had an amphophilic-to-basophilic cyto-
plasm. Tumor nuclei were round to oval with moderate
nuclear pleomorphism and prominent nucleoli (Figure 4).
Mitotic figures were not identified. Capsular and vascular
invasion was not present. By immunohistochemical stain-
ing, the tumor cells were reactive to CD 56, synaptophysin,
and chromogranin A. The sustentacular cells surrounding
the tumor clusters were also highlighted by immunostaining
for S100. The lymph nodes dissected were free of malig-
nancy. Both histomorphology and immunoprofiles of the
tumor were typical of paraganglioma. Hypertensive
urgency developed after the operation which was
controlled with continuous intravenous nicardipine.
Collected 24-h urine catecholamine data showed thatFigure 1 Transabdominal ultrasonogram demonstrated a
hypoechoic mass (arrow) in the uncus of the pancreas.
Figure 3 Magnetic resonance imaging with contrast
enhanced (T2 weighted) revealed an enhancing lesion (arrow)
in the uncus of the pancreas.norepinephrine levels were 175 mg/day (normal value:
<97 mg/day) and vanillylmandelic acid levels were
8.06 mg/day (normal value: 1e7.5 mg/day). After 7-day
nicardipine treatment, we gradually shifted to oral anti-
hypertensive agents. Finally, the patient was successfully
discharged with oral doxazosin (4 mg) one tablet per day.
The patient had no clinical signs, symptoms, or family
history suggestive of multiple endocrine neoplasia or Von
HippeleLindau disease.
Figure 4 Tumor was composed of polygonal cells arranged in
characteristic nested pattern “Zellballen.” Cytoplasm was
amphophilic to basophilic.
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Paragangliomas are rare extra-adrenal pheochromocytomas
which originate from chromaffin cells within the ganglia of
the sympathetic trunk and of the celiac, renal, suprarenal,
and hypogastric plexuses. The incidence is about one in 2
million [1]. Although paragangliomas can be found within
organs or soft tissues, the most common location is the
infra-renal area near the origin of the inferior mesenteric
artery where the organs of Zuckerkandl are located [2].
Pancreatic paragangliomas are extremely rare and only 18
cases are currently documented in English literature,
including this present manuscript [3e5]. It remains unclear
whether pancreatic paraganglioma represents an extension
from a retroperitoneal tumor or ectopic paraganglia of
visceral origin. In our case, the tumor was encapsulated
within the pancreatic uncinate process. Although pancre-
atic paragangliomas are reported in different locations of
the pancreas, the most common location is the head of the
pancreas (13 of the 18 cases). Two lesions were located in
the body and three lesions in the tail of the pancreas [3e5].
Most of the extra-adrenal retroperitoneal para-
gangliomas are reported to be functional [6]. In contrast,
most of the pancreatic paragangliomas are reported to be
nonfunctional [5]. Functional paragangliomas can secrete
catecholamine and usually present with hypertension,
palpitation, and headache. Nonfunctional tumors may
present with abdominal pain, palpable mass, or incidental
image findings.
Typical imaging findings are characterized as well-defined
hypervascular masses. Cystic degeneration change or hem-
orrhagic necrosis can be detected within larger masses [7].
Several image findings were reported to be a clue for differ-
ential diagnosis, including: (1) early enhancement of the
prominent draining veins during arterial phase [7]; and (2)
absence of biliary dilation despite of large tumor size [8].
However, these findings are not specific. The differential
diagnosis of pancreatic hypervascular tumors includes
neuroendocrine tumors and paragangliomas. Laboratory
diagnosis can be established with high urine catecholamine
metabolites and metaiodobenzylguanidine scintigraphyexamination. Pathological diagnosis can be obtained by
endoscopic ultrasound/fine needle aspiration sampling or
surgical resection. Without proper preoperative evaluation,
tissue proof by endoscopic ultrasound/fine needle aspiration
or resection is reported to be associated with higher risk,
including hypertensive crisis [9]. Therefore, in cases where
patients have with histories of pancreatic hypervascular
tumors and malignant hypertension, functional para-
ganglioma should be taken into consideration. Proper labo-
ratory examination should be done before tissue sampling.
Although most paragangliomas grow slowly and follow a
benign course, the possibility of malignant transformation
makes surgical resection the treatment of choice. Malig-
nancy is unpredictable, and the only criterion for the diag-
nosis of malignancy is distant metastasis at the site where
paraganglionic tissues do not exist [3]. Octreotide is reported
to be able to control tumor size and ameliorate symptoms of
catecholamine excess in unresectable cases [10].
In summary, we report an extremely rare case of func-
tional pancreatic paraganglioma. Despite its rarity, para-
ganglioma should be a part of the differential diagnosis of
pancreatic hypervascular tumor. Proper laboratory exami-
nation of catecholamine excess should be performed
before obtaining tissue samples, especially for patients
with a history of malignant hypertension.
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